Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
16 Aug 2024 18:33
PT Merck Tbk (MERK), a pharmaceutical company under Merck Holding GmbH from Germany, booked net profit of IDR 47.2 billion in the first half (H1) of 2024.
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
12 Jun 2024 09:25
PYFA Australia Pty Ltd (PAPL), an entity under PT Pyridam Farma Tbk (PYFA), has secured extra capital of USD 99.57 million or equal to approximately IDR 1.07 trillion.
03 Jun 2024 08:41
PT Kimia Farma Tbk (KAEF), a state-owned pharmaceutical company through PT Bio Farma (Persero), reported worsening loss in 2023, down to IDR 1.48 trillion.
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.
10 Nov 2023 06:01
PT Bukit Asam Tbk (PTBA) is exploring cooperation in the fields of pharmaceuticals to medical devices, by signing a Memorandum of Understanding (MoU) with PT Kimia Farma Tbk (KAEF).
12 Sep 2023 19:52
PT Soho Global Health Tbk (SOHO), a pharmaceutical company with a market capitalization of IDR 6.15 trillion, will carry out a stock split with a ratio of 1:10.
07 Jul 2023 19:29
PT Kimia Farma Tbk (KAEF) opened 23 new outlets simultaneously on Friday (7/7) today, which are spread across various provinces in Indonesia.
15 May 2023 07:21
PT Merck Tbk (MERK), a pharmaceutical company under Merck Group, Germany, announces its intention to share cash dividend of IDR 143.36 billion, equal to IDR 320 per share, that will be taken out of its net profit in 2022.